Effect of prophylactic injection of magnesium sulfate versus placebo on shivering after cesarean section under spinal anesthesia

Phase 3

Recruiting

• Conditions: Shivering.; Tremor, unspecified; R25.1

• Registration Number: IRCT20120215009014N380
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Age of 18 to 45 years old
Pregnant women
Candidate for cesarean section

Exclusion Criteria

Body temperature above 37.5 or below 36 degree centigrade
Renal or liver diseases or muscular weakness
Uncontrolled thyroiditis disease
Parkinson disease
Dis-autonomy
Raynaud's syndrome
Cardiovascular disease
Alcohol consumption
Taking vasodilator medications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Shivering after spinal anesthesia. Timepoint: Every 15 minutes until the end of the patient's presence in the recovery room. Method of measurement: With a clinical examination.